| GC48407-1mg |
|
— |
Aliskiren-d6 (hemifumarate)
|
0 |
— |
|
|
|
| GC48406-1mg |
|
— |
PSI (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48405-10mg |
|
— |
|
0 |
— |
|
|
|
| GC48405-5mg |
|
— |
|
0 |
— |
|
|
|
| GC48405-1mg |
|
— |
|
0 |
— |
|
|
|
| GC48404-10mg |
|
— |
Ac-YVAD-pNA (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48404-5mg |
|
— |
Ac-YVAD-pNA (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48404-1mg |
|
— |
Ac-YVAD-pNA (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48403-100mg |
|
67219-55-0 |
N4-Benzoyl-5′-O-(4,4′-dimethoxytrityl)-2′-deoxycytidine
|
0 |
— |
|
|
|
| GC48402-100μg |
|
— |
Cholesteryl Palmitate-d9 MaxSpec® Standard
|
0 |
— |
|
|
|
| GC48401-10mg |
|
— |
Risuteganib (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48401-5mg |
|
— |
Risuteganib (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48401-1mg |
|
— |
Risuteganib (trifluoroacetate salt)
|
0 |
— |
|
|
|
| GC48400-10mg |
|
71781-33-4 |
Taurocholic Acid 3-sulfate (sodium salt)
|
0 |
— |
|
|
|
| GC48400-5mg |
|
71781-33-4 |
Taurocholic Acid 3-sulfate (sodium salt)
|
0 |
— |
|
|
|
| GC48400-1mg |
|
71781-33-4 |
Taurocholic Acid 3-sulfate (sodium salt)
|
0 |
— |
|
|
|
| GC48400-500μg |
|
71781-33-4 |
Taurocholic Acid 3-sulfate (sodium salt)
|
0 |
— |
|
|
|
| GC48399-25mg |
|
1334953-95-5 |
|
0 |
— |
|
|
|
| GC48399-10mg |
|
1334953-95-5 |
|
0 |
— |
|
|
|
| GC48399-5mg |
|
1334953-95-5 |
|
0 |
— |
|
|
|
